Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-02, Stock:PFE, The news for the past five days is as follows:
2021-01-26: NEWS1: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS2: ‘If you’re a teacher, it’s a lot safer to be in school:’ InHouse Physicians CEO.NEWS3: Doctor on Biden’s vaccine goals: ‘I don’t think that those numbers would be realistic at all’.NEWS4: Coronavirus update: J&J to release vaccine data next week; strain from Brazil confirmed in US.NEWS5: More countries have banned travel from South Africa as its Covid-19 variant poses a vaccine challenge.NEWS6: Markets continue to flitter between stimulus hope and COVID concerns: strategist.NEWS7: It will take ‘significant mutations’ for COVID-19 vaccines to be ineffective: Doctor.NEWS8: J&J CEO: Expect Phase 3 results for its COVID-19 vaccine candidate early next week.NEWS9: Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline.NEWS10: Expect Treasury Yields to Start Climbing Again Soon, BCA Says.NEWS11: Johnson & Johnson (JNJ) Surges to All-Time High.NEWS12: Breakout Watch: IPO Leader, Pfizer Vaccine Partner MRVI Stock Enters Buy Zone.NEWS13: Pfizer's (PFE) Bavencio Gets EU Nod for First-Line Bladder Cancer.NEWS14: How Long Will Coronavirus Vaccine Drive Moderna (MRNA) Stock?.NEWS15: Britain will work with EU to avoid vaccine disruption, UK health minister says.NEWS16: Moderna on track to deliver 200 million doses of its COVID vaccine to U.S. govt by end-June.NEWS17: Is Pfizer A Great Dividend Stock?.NEWS18: WRAPUP 2-Keep your supply promises, EU tells vaccine makers as deliveries wobble.NEWS19: No serious COVID-19 cases among Israelis given Pfizer shot, minister says.NEWS20: Merck Just Scrapped Its Coronavirus Vaccines — Is Merck Stock A Buy?.NEWS21: Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis.NEWS22: Could Pfizer Be a Millionaire-Maker Stock?.NEWS23: 3 Stocks Warren Buffett Would Love.NEWS24: Pfizer Expects to Deliver Covid Vaccines Quicker Than Expected.NEWS25: Why Pfizer Will Make More Money Than Originally Expected in 2021.NEWS26: Comic: Covid-19 in 2021: Déjà Vu, or the Beginning of the End?.NEWS27: Exclusive: Scarce niche syringes complicate U.S. plan to squeeze more COVID shots from Pfizer vials.
2021-01-27: NEWS1: Pfizer vaccine only slightly less effective against key S.African mutations -study.NEWS2: Is Pfizer Stock A Buy As Wall Street Awaits New Covid Jab From J&J?.NEWS3: Doctor: 'These viruses are built to mutate'.NEWS4: COVID-19 Response Team: Federal government has 2-3 day vaccine supply on hand, remainder sent to states.NEWS5: White House exploring tapping drugmakers to produce rivals' vaccines.NEWS6: U.S. CDC sees lower rates of allergic reaction after Pfizer vaccine.NEWS7: Coronavirus update: Biden announces changes to vaccine rollout.NEWS8: Merck's (MRK) Keytruda Gets EC Nod for MSI-H Colorectal Cancer.NEWS9: Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?.NEWS10: Moderna: U.S. gov plans to order an additional 100 million doses of its COVID-19 vaccine.NEWS11: Governments Are Scrambling for Vaccine Doses. More Supplies Seem Imminent..NEWS12: Regeneron says its COVID-19 antibody cocktail still works against new strains in lab test.NEWS13: Sanofi teams up with BioNTech and Pfizer to help fix Europe’s vaccine shortage.NEWS14: Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA).NEWS15: INSIGHT-Raging virus, few shots. How Brazil missed its chance to secure COVID-19 vaccines.NEWS16: The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech and AstraZeneca.NEWS17: Bulgarian care home patients get first shots in slow vaccine rollout.NEWS18: Sanofi To Manufacture 125 Million COVID-19 Vaccine Doses For Rival Pfizer-BioNTech.NEWS19: Sanofi confirms its will supply over 125 millions Pfizer-BioNTech doses to the EU.NEWS20: Pfizer and BioNTech Get Help From Sanofi on Vaccine Production.NEWS21: Dry ice, containers and overworked doctors: the hurdles for Japan's vaccine roll-out.
2021-01-28: NEWS1: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS2: Honeywell’s Global Supply Chain Chief on how the company administered 16K vaccinations in one weekend.NEWS3: Novavax Stock Surges After Covid Vaccine Proves Nearly 90% Effective.NEWS4: A Golden Era of Medicine: Join Mira Life Science Ventures CEO for Fireside Chat Feb. 4.NEWS5: Drugmakers examine effectiveness of COVID-19 vaccines and treatments against new, more infectious South African strain.NEWS6: Covid Vaccine Stocks Pop Despite WHO Guidance Against Shots In Pregnancy.NEWS7: February Outlook: Six Things To Look For Include Fed Testimony, Vaccine Progress, Big-Box Earnings.NEWS8: Doctor: 'Double masking is actually not a bad idea'.NEWS9: FOCUS-Racing the virus: Why tweaking vaccines to fight variants won't be simple.NEWS10: Doctor on COVID-19 variants: It’s becoming clear that ‘we will need boosters’.NEWS11: Sanofi (SNY) to Manufacture BioNTech's Coronavirus Vaccine.NEWS12: English health authority says AstraZeneca shot gives "reassuring" immune responses in elderly.NEWS13: As EU battles AstraZeneca shortages, U.K. races ahead with manufacture of new COVID vaccine.NEWS14: The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO.NEWS15: Moderna and Pfizer Vaccines Still Look Safe, CDC Says.NEWS16: Northern France health agency pushes back date of some first COVID vaccination doses.NEWS17: REFILE-INSIGHT-Pandemic spurs quest to enroll more Black Americans in vaccine trials.NEWS18: Novartis in Talks to Join Pharma Industry’s Covid Vaccine Push.NEWS19: Preliminary Study Finds Pfizer's COVID-19 Vaccine Effective Against UK, South Africa Variants: WSJ.NEWS20: Better Buy: Pfizer vs. BioNTech.NEWS21: Racing the virus: Why tweaking the vaccines won't be simple.NEWS22: FOCUS-Racing the virus: Why tweaking the vaccines won't be simple.NEWS23: 4 Stocks Warren Buffett Is Likely to Add to in 2021.NEWS24: CORRECTED-Swiss flag possible Moderna COVID-19 vaccine delivery shortfall -Blick.NEWS25: Pfizer to continue vaccine supply to Italy even if Rome files lawsuit: CEO to paper.NEWS26: Pfizer to continue vaccine supply to Italy even if Rome files lawsuit - CEO to paper.
2021-01-29: NEWS1: This IBD Stock Of The Day Is Eyeing Not One — But Three — Buy Points.NEWS2: J&J Slides On Less Effective Covid Vaccine; Moderna, BioNTech Pop.NEWS3: Novavax Catapults To 6-Year High After Covid Vaccine Proves Highly Effective.NEWS4: US STOCKS-Wall St drops after J&J vaccine data, GameStop effect weighs.NEWS5: Biden aims to reopen schools in 100 days.NEWS6: Doctor: You should take 'any vaccine that is authorized and available'.NEWS7: Ecuador opens probe of health minister over COVID vaccine influence peddling.NEWS8: Now More Than Ever Why Pfizer Stock Is a Buy.NEWS9: Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350.NEWS10: Doctor: COVID-19 vaccines have been the ‘highlight of our response’.NEWS11: Novavax Stock Soars as Its Covid-19 Vaccine Outperforms J&J’s.NEWS12: U.S. likely to start COVID-19 vaccination in children by late spring or early summer- Fauci.NEWS13: The new South African strain is more infectious, and it’s also making COVID-19 vaccines less effective.NEWS14: Here's where the world stands in the fight against COVID-19.NEWS15: J&J Vaccine Provides Strong Shield Against Severe Covid.NEWS16: Vaccine hopes boosted by data from Novavax and J&J, but fears over new variants remain.NEWS17: European Cities Forced to Halt Vaccinations as Supply Issues Reach Crisis Point.NEWS18: Pfizer's (PFE) Key Brands Likely to Drive Its Q4 Earnings.NEWS19: Pharma Stock Roundup: JNJ, NVS Q4 Earnings, MRK & LLY's Coronavirus Updates.NEWS20: Johnson & Johnson says one-dose vaccine is 72% effective in U.S..NEWS21: Will Glaxo (GSK) Q4 Earnings Recover From Coronavirus Woes?.NEWS22: Moderna (MRNA) at High as Johnson & Johnson (JNJ) Vaccine Disappoints.NEWS23: Understanding Pfizer's Unusual Options Activity.NEWS24: J&J Vaccine Prevents Serious Illness, but Falls Short of Competitors.NEWS25: Coronavirus update: J&J vaccine 72% effective in US trial; South African strain found in US.NEWS26: EU threatens legal action to secure more doses as vaccine shortage reaches crisis point.NEWS27: Can Moderna and Pfizer Meet President Biden's Vaccine Goals?.NEWS28: Covid-19 Vaccine Trial Data Is Good News for Novavax.NEWS29: J&J COVID-19 vaccine is 72% effective in the U.S., and 66% overall in large trial.NEWS30: Better Coronavirus Stock: Johnson & Johnson vs. Pfizer.NEWS31: Look Out, Pfizer and Moderna: Here Comes Novavax.NEWS32: Why the Market Is So Bullish About Trillium Therapeutics.NEWS33: Novavax Says Its Vaccine Is 89% Effective in Britain–but Not as Effective Against the South African Variant.NEWS34: AstraZeneca to seek Japan's approval of COVID-19 vaccine as early as mid-Feb -Yomiuri.
2021-02-01: NEWS1: Bank of America downgrades Moderna stock over concerns about valuation.NEWS2: 'We need to get to a very high level of vaccination compliance across the planet before we can really slow this virus down': Expert.NEWS3: Moderna Stock: Buy the Dip?.NEWS4: Pfizer–BioNTech partnership pledges 75 million more vaccine doses to help ease the EU bloc’s shortage.NEWS5: Time for more record earnings reports from Big Tech, led by Amazon’s first $100 billion quarter.NEWS6: Pfizer Earnings: What to Look For From PFE.NEWS7: BioNTech-Pfizer partnership pledges 75 million more vaccine doses to help ease the EU bloc’s shortage.NEWS8: Why Bank of America Thinks Moderna Stock Has Gone High Enough.NEWS9: BioNTech says back on schedule to deliver COVID-19 vaccine doses to EU.NEWS10: Distribution of the COVID-19 vaccine has been ‘more of an operational challenge' than it should have been: Doctor.NEWS11: Drug/Biotech Stock Earnings on Feb 2: AMGN, PFE & CTLT.NEWS12: Another Big Week for Q4 Earnings, Econ News; ON Semi Beats.NEWS13: Novavax Surges On Highly Effective Covid Shot; Is NVAX Stock A Buy?.NEWS14: Pfizer Earnings Preview.NEWS15: BioNTech now plans to produce 2 billion doses of its COVID-19 vaccine in 2021.NEWS16: Phoenix Venture Partners LLC Raises 3rd Fund, PVP III LP.NEWS17: Pfizer, United Parcel Service, Amazon, Google and Boeing are part of Zacks Earnings Preview.NEWS18: 3 Dividend Stocks Ideal for Retirees.NEWS19: Top Earnings To Watch This Week: Amazon and Alphabet.NEWS20: Japan ramps up ultra-cold freezer output ahead of vaccine roll-out.NEWS21: AstraZeneca Boosts EU Vaccine Supply.NEWS22: EU says Pfizer/BioNTech to deliver 75 million extra vaccine doses in second quarter.NEWS23: COVAX to send AstraZeneca shot to Latin America, some states to get Pfizer too.NEWS24: Malaysia to receive first batch of Pfizer vaccines on Feb. 26 - report.

Answer: Decrease